ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
FDA Patent Settlement legislation - House
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
Pharmacy PHA
Medicare coverage Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D & B Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
Health Issues HCR
Value of Prescription Drugs Value Based Agreements (VBAs)- PAVE Act Biosimilars Rebate Reform Pricing Transparency: SPIKE Act, HR 2069 and STAR Act, HR 2113 Oncology Care Model - CMS Personalized Medicine H.R. 6, SUPPORT for Patients and Communities Act -House & Senate
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
Medicare/Medicaid MMM
Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Rebate reform Medicare Part B IPU proposed rule - House Changes to the Medicaid Drug Rebate Program (AMP Cap) - House Medicare Part B Intl. Pricing Index ANPRM - Senate & House & CMS
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | . |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.